chrisvoncsefalvay/vaers-outcomes huggingface dataset:
During a conversation, I was told I began smacking my lips then proceeded to completely ?zoneout? for  5-7 minutes. My arm was touched and I was asked a couple of questions to which I did not respond. After a few minutes, I became alert and continued conversation where I left off. I was unaware any of this was happening. I was pretty much wiped out for about 5 days. I have never had a seizure before.
Breakthrough case admission after 3 vaccines Pfizer 1/22/21 Lot# EL9261;  Pfizer 2/12/21 Lot# EM9810;  Pfizer 11/2/21 Lot# FF2593;
STABLE ANGINA 3/13/2023  -  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Injection-site reaction; Redness at injection site/red streak half an inch from the injection site; Itchiness; Arm is tender to the touch; This case was reported by a consumer via call center representative and described the occurrence of local reaction in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th October 2020, the patient received the 1st dose of Shingrix. On 7th October 2020, less than a day after receiving Shingrix, the patient experienced local reaction, injection site erythema, pruritus and tenderness. On an unknown date, the outcome of the local reaction, injection site erythema, pruritus and tenderness were not recovered/not resolved.   It was unknown if the reporter considered the local reaction, injection site erythema, pruritus and tenderness to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced redness at the injection site, itchiness, and her arm is tender to the touch. She states it started out as a small, red streak half an inch from the injection site on wednesday night. On Thursday morning, she noticed it started to spread down and around to the back of the right arm. She states the reaction was ongoing still the time of reporting, but the redness was not as red and the tenderness was not as tender.  For 1st dose refer case US2020AMR202892. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR202892:same reporter
Left arm soreness, fever, chills.  Increased soreness and swelling 2 days later with new onset of redness.  Ibuprofen was taken-400mg every 4 hours which helped soreness.  Seen in office 4/22/2011.
Getting a migraine headache; Knot at injection site; Chills; Joint aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Getting a migraine headache), INJECTION SITE NODULE (Knot at injection site), CHILLS (Chills), ARTHRALGIA (Joint aches) and NAUSEA (Nausea) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concurrent medical conditions included Celiac disease (Autoimmune Celiac disease) and Complex regional pain syndrome (Complex regional pain syndrome.).   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced MIGRAINE (Getting a migraine headache), INJECTION SITE NODULE (Knot at injection site), CHILLS (Chills), ARTHRALGIA (Joint aches) and NAUSEA (Nausea). At the time of the report, MIGRAINE (Getting a migraine headache), INJECTION SITE NODULE (Knot at injection site), CHILLS (Chills), ARTHRALGIA (Joint aches) and NAUSEA (Nausea) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable.  No concomitant and treatment medication were provided   This case was linked to US-MODERNATX, INC.-MOD-2021-049473 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049473:CROSSLINKED WITH DOSE 1
Mild rash post 1st vaccine. Diffuse red, angry, itching rash with fluid filled blisters post 2nd vaccine.  Initially treated with topical corticosteroids.  After no improvement, treated with low dose Prednisone for 14 days.  No improvement noted, stronger dose topical corticosteroids.  No improvement noted, high dose Prednisone tapering over 30 days.  Began in February, 2021.  The only improvement is the rash is no longer present all over the body but is located on the hands, forearms and shins.  Remains red, itchy and has tiny fluid filled blisters.
Patient with history of fainting after receiving shots, seen slipping off chair, assisted to ground by staff, patient altered level of consciousness and weak. Patient assisted to gurney chair, placed in trendelenburg position, vitals taken, HR in the high 40s, patient slowly began to regain consciousness, able to speak, take in fluids and crackers, assisted to sitting position, tolerated well. Patient then allowed to stand, denied dizziness. Patient declined ED transfer or medical follow up, red flag symptoms discussed, Alert and Oriented x 4, transferred via wheelchair to car, fiance drove car.
Not Feeling well; Body aches; My body was very sore; I Felt horrible; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not Feeling well), PAIN (Body aches), PYREXIA (Fever), PAIN (My body was very sore) and MALAISE (I Felt horrible) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced MALAISE (Not Feeling well), PAIN (Body aches), PYREXIA (Fever), PAIN (My body was very sore) and MALAISE (I Felt horrible). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, MALAISE (Not Feeling well), PAIN (Body aches), PYREXIA (Fever), PAIN (My body was very sore) and MALAISE (I Felt horrible) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Information has been received from a registered nurse concerning a 16 month old male patient with a history of asthma who on 28OCT2003 was vaccinated with a dose of varicella virus vaccine live (lot 646232/0543N). Concomitant therapy included measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live (lot 645405/0132N) given in the left thigh on 28OCT2003, other concomitant medication included levalbuterol hydrochloride and budesonide. On 24FEB2004 the patient experienced "breakthrough". He developed a vesicular rash. He was treated with acyclovir, diphenhydramine hydrochloride and calamine lotion. It was noted that the patient had a runny nose about one week before the lesions appeared. No lab diagnostic studies were performed. No product quality complaint was involved. Additional information has been requested.  Follow up information On 11/25/2003 the patient was vaccinated in the left thigh with a first dose of influenza virus whole virion 3v vaccine inactivated (Fluzone). At the time of vaccination it was noted that the patient had a developmental delay was physically well and was being followed by GI, Pulmonary, neurology, opthamalogy, ENT and Ortho.  Follow up information from the registered nurse indicated that the patient saw pulmonologist on 02/24/2004 and the patient history of cold URI and was congested. The patient had a rash and a vesicle was noted and varicella was questioned. The patient was instructed to go to the ER if respiratory distress was noted. The patient was started on acyclovir BID, which was discontinued on 02/27/2004. It was reported that the patient recovered in 2 weeks. No further information is available.
Box 9 - HCTZ 25mg, Potassium ER 8meq, Estradiol 0.05mg, Metformin ER 500mg, Seroquel 200mg, Atorodrastatin 40mg, Singular 10mg, Narco 10/325  Went home and laid down. Started feeling tremendously painful muscle spasms under breasts, both calves, both hands, all fingers, down lower back. Felt a rush of blood to brain. Current day, gait is uneven and I feel lightheaded when I try to use my legs. Very fatigued and dizzy, unable to shower and have to crawl vs walk.
My child age 2 was given the wrong vaccines on 8/19/23 that were meant for his brother  who is 4 and was hospitalized for seizures on 8/29/23 10 days after the wrong vaccine was administered, he had another seizure on 9/29/23 he was then hospitalized again and admitted.  We followed up with the pediatrician office after both incidents and we verified with the staff that the wrong vaccines had been given to our children.
mom said pt cried uncontrollably from the time of vax until clinic 930AM-1PM; pt was seen by MD who could find nothing wrong @ 3PM;told to observe pt next 48hrs & bring back if crying observed;
high fever; Initial information was received on 26-Mar-2021 regarding an unsolicited valid serious case from a consumer/non-healthcare professional.  This case involves a male patient (age not reported) who had high fever (pyrexia), after he received DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE.  The patient's past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date (over 30 years ago), the patient received a dose of suspect DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (produced by unknown manufacturer) (lot number and expiry date not reported) via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date (over 30 years ago), the patient developed a serious high fever (pyrexia) (unknown latency) following the administration of DIPHTHERIA and TETANUS AND ACELLULAR PERTUSSIS VACCINE. The patient was hospitalized for this event.  The reporter wanted to know the ingredients of the Pfizer Covid (coronavirus disease) vaccine because the patient had a reaction to the Pertussis vaccine and went to the hospital. He wanted to know if they both vaccines had the same ingredients and that he had checked everywhere to find this information. He was looking if it is safe for him to take it, anyone had a reaction to the product who used Pertussis vaccine.   It was unknown if there were lab data/results available.  An unknown corrective treatment was received at the time of hospitalization.  On an unknown date, the patient recovered from the event.   Information on the batch number was requested.; Sender's Comments: This case concerns a male patient (age not reported) who had pyrexia after vaccination with DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (produced by unknown manufacturer). Time to onset is compatible with the role of vaccine. Additional information regarding patient's medical history, condition at the time of vaccination, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
Patient had only the PEDIARIX shot today. Approximately 5 minutes after she had the injection, while she was playing and waiting for her other siblings to get their shot. She was standing and talking with her Mother on the opposite side of my desk when she just fell backwards onto the floor. She began to stiffen, her eyes rolled up into her head and were only partially visable. She began exhibit Decerebrate posturing. Her Mother started calling out her name with no response from the patient. Her Mom then began to gently shake her shoulders, and when I came around the desk and started assessing her, she came to. She started to cry, hug her Mom and said "I don't feel good". The whole episode lasted 15 to 20 seconds. Patient was very pale, but no labored breathing and heart rate was normal. I called her physician, and Dr. requested to see her right away.
On 10/21/2121 patient was given a full dose Moderna dose, for dose 3. Patient forms reviewed and patient is NOT immunocompromised. Patient received one booster following this on 06/30/2022 and a bivalent dose on 01/11/2023, which is when this error was noticed.
The patient was walking to the vaccination room 2 min after receiving vaccination and patient fell to the ground with no obvious cause. Staff placed pt in chair and pt rested. Pt states she felt better and declined further assistance/interventio.
Had inject site reaction (8cmx7cm area of erythema, warmth & tenderness) 4 hrs post vax @ DTP site; also had fever of 103 evening of vax; seen in MD office; tx'd w/ice packs & Pediazole; 8APR afebrile but reaction @ site persists;
Vomiting 8+ times over 3 hours from 8-11 p. Today, lethargy, no appetite, thirsty, one more vomit. Fever, hot all over, chills.
Developed fever of 101 the morning after which was 6/6/2019 lasting a few days.  Had a few rash spots on chest which all have cleared up in about a week.
NO ADVERSE EVENT- IMMUNIZATION WAS ADMINISTERED AT DAY 15 OF 21-DAY SERIES BETWEEN FIRST AND SECOND DOSE OF THE COVID-19 VACCINE.
Rash at the injection site; Circle just below the injection site; Itchy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (Rash at the injection site), INJECTION SITE REACTION (Circle just below the injection site) and PRURITUS (Itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced INJECTION SITE RASH (Rash at the injection site), INJECTION SITE REACTION (Circle just below the injection site) and PRURITUS (Itchy). At the time of the report, INJECTION SITE RASH (Rash at the injection site), INJECTION SITE REACTION (Circle just below the injection site) and PRURITUS (Itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. No Treatment information  provided
Subjective; Patient is a 38 yo male who was seen at COVID Vaccine Clinic today for his second  dose of the COVID 19 vaccination. He was given the Moderna vaccination in the right deltoid muscle.   During his 15 minute waiting period after the injection, the patient began to experience lightheadedness and diaphoresis, chest tightness that is reproducible by provider with palpation.  He denied difficulty breathing, wheezing, throat tightness and dizziness.   This provider was notified of patient reaction and he was then assessed in the emergency bay area.   Monitored patient for severe reaction symptoms, including but not limited to blood pressure abnormality , rapid progression of symptoms, respiratory distress and vomiting.   During monitoring, patient complains of shortness of breath and chest tightness.  SpO2 100% room air, blood pressure elevated at 152/104 at 0840, 147/112 at 0900.  Patient is alert and oriented.  O2 per NC placed at 0900, SpO2 at 100%.  Patient was able to eat and drink during monitoring.  Blood glucose is 107.  BP at 0910 150/93.  He is not on any prescribed medications.  He denies past medical history.  Patient to go to ER for further evaluation of chest pain.      ALLERGY REVIEW OF SYSTEMS:  Patient complains of chills, chest tightness and shortness of breath    Pain behind both eyes:  Pt once in bed, reported worsening chest tightness/sob. stabilized symptoms during his stay.:  Nausea:  lightheadedness:     Previous Reactions:  First dose of Moderna with headache, nausea, fatigue x 2 days.    Objective    Vitals Vitals:   02/09/21 0830 02/09/21 0842 BP: (!) 164/85 (!) 152/104 Pulse: 73 72 Temp: 98.8 °F (37.1 °C)   SpO2: 100%        Blood Sugar 107 collected at 0838     Physical Exam Eyes:     Extraocular Movements: Extraocular movements intact.     Pupils: Pupils are equal, round, and reactive to light.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Pulses: Normal pulses.     Heart sounds: Normal heart sounds.  Pulmonary:     Effort: Pulmonary effort is normal.     Breath sounds: Normal breath sounds.     Comments: Hyperventilating at times. Chest:     Chest wall: Tenderness present.  Abdominal:     Comments: Periods of belching  Musculoskeletal:     Right lower leg: No edema.     Left lower leg: No edema.  Neurological:     General: No focal deficit present.     Mental Status: He is alert and oriented to person, place, and time.     Gait: Gait normal.  Psychiatric:        Mood and Affect: Mood is anxious.        Speech: Speech normal.        Thought Content: Thought content normal.        Cognition and Memory: Cognition normal.        Judgment: Judgment normal.         Assessment/Plan  Treatment included: water, snacks and Pepcid, Tylenol Follow up response to treatment: good. Patient discharge: Transported to ED by ambulance.  Differential Diagnosis: Vaccine-Related Anxiety (include misc mental health) and Red flag symptoms (CP, SOB, NVD, Visual/Neuro concerns)   Patient transported to ED. ER notified of patient's coming.
Per internal medication related event reporting system: "Family member called today asking about an immunization that was administered on 12/14/21. Caller was making sure patient received her Covid booster and not a second flu immunization. Review of record indicates patient received a flu immunization on October 20,2021 and then received another flu immunization on December 14, 2021. There is no documentation that a third, or booster, Covid immunization was administered. Family member was advised of these facts. "
Patient received 0.5 ml of Pfizer covid 19 vaccine for their second booster. Patient is not experiencing any side effects at the moment the phone call was made but was instructed to monitor any unusual side effects/symptoms for the next week.
had COVID after 1st dose; A spontaneous report was received from a Consumer concerning a 48-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event, had covid after 1st dose.  The patient's medical history was not provided. Concomitant medications reported were Lisinopril, Rosuvastatin for drug use for unknown indication.  On 20 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012L20A) intramuscularly for prophylaxis of COVID-19 infection. On 17 Feb 2021, prior to the onset of events, the patient received their second of two planned doses of mRNA-1273 (batch : unknown) intramuscularly in the left arm for the prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event, had COVID after 1st dose.  Treatment details included None.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, had covid after 1st dose, was unknown.
How soon can I expect to feel better; This case was reported by a consumer via(Shingrix GSK Chatbot) interactive digital media and described the occurrence of feeling unwell in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd July 2021, the patient received the 1st dose of Shingrix. In July 2021, less than a week after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional details were provided as follows: The case was reported by the consumer for herself or himself. The age at vaccination was not reported. The patient stated that, he or she received first dose of the Shingrix vaccine and am experiencing all the symptoms listed.  The patient asked how he or she soon could expect to feel better and would this happen again with his or her second dose. No further information was reported.
Tip of tongue feels slightly enlarged; Salty taste in mouth; Tingle sensation on tip tongue; This is a spontaneous report from a contactable consumer (patient). This 46-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot# EL3302), via an unspecified route of administration on 22Jan2021 08:00 at single dose on the right arm for COVID-19 immunization. Medical history included high blood pressure and COVID-19. No allergies to medications, food, or other products. The patient's concomitant medications included amlodipine and ethinylestradiol/ferrous fumarate/norethisterone acetate (LO LOESTRIN FE) received within 2 weeks of vaccination. Patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was hospital. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Jan2021 12:00, the patient experienced salty taste in mouth for over 2days. Tingle sensation on tip tongue. Tip of tongue feels slightly enlarged. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. No treatment received for the adverse event. Outcome of the events was not recovered.
broke out with rash on both arms; This spontaneous case was reported by a consumer and describes the occurrence of RASH (broke out with rash on both arms) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043821A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (broke out with rash on both arms). At the time of the report, RASH (broke out with rash on both arms) had resolved. According to TCR dated 24-May-2021, She (Patient) reports rash resolved after a few days. She feels fine now.          The patient also states that she was on thyroid medication and quite a bit of medicine which she did not disclose. The treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: TCR: attached -Outcome of event was updated
Pediarix, Prevnar, ActHib and Rotateq given on 4/25/07 about 12 noon developed irritability and redness of sites of all 3 vaccines at 1400 Tylenol given at 1600 expressive crying working at 1800. Resolved by 4/26/607 an (Noted low grade fever 4/26/07 at 1630)
felt like I had the flu; nauseous; threw up; chilled; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (felt like I had the flu), NAUSEA (nauseous), VOMITING (threw up) and CHILLS (chilled) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer (Breast cancer 12 years ago.).    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like I had the flu), NAUSEA (nauseous), VOMITING (threw up) and CHILLS (chilled). The patient was treated with PARACETAMOL (TYLENOL) on 06-Mar-2021 at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (felt like I had the flu), NAUSEA (nauseous), VOMITING (threw up) and CHILLS (chilled) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.